首页> 外文OA文献 >Absolute Lymphocyte Count Predicts Immune-Related Adverse Events in Patients With Non-Small-Cell Lung Cancer Treated With Nivolumab Monotherapy: A Multicenter Retrospective Study

【2h】

Absolute Lymphocyte Count Predicts Immune-Related Adverse Events in Patients With Non-Small-Cell Lung Cancer Treated With Nivolumab Monotherapy: A Multicenter Retrospective Study

机译：绝对淋巴细胞计数预测用Nivolumab单药治疗的非小细胞肺癌患者免疫相关不良事件：多中心回顾性研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Saeka Egami; Hitoshi Kawazoe; Hironobu Hashimoto; Ryuji Uozumi; Toko Arami; Naomi Sakiyama; Yuichiro Ohe; Hideo Nakada; Tohru Aomori; Shinnosuke Ikemura; Koichi Fukunaga; Masakazu Yamaguchi; Tomonori Nakamura;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Association of Immune-Related Adverse Events with Clinical Benefit in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Nivolumab [J] . Toi Yukihiro, Sugawara Shunichi, Kawashima Yosuke, The oncologist . 2018,第11期

机译：用Nivolumab处理的晚期非小细胞肺癌患者临床益处的免疫相关不良事件的关联
2. Association Between Immune-Related Adverse Events and Clinical Efficacy in Patients with Melanoma Treated With Nivolumab: A Multicenter Retrospective Study [J] . Okada Naoto, Kawazoe Hitoshi, Takechi Kenshi, Clinical therapeutics . 2019,第1期

机译：用Nivolumab治疗的黑色素瘤患者免疫相关不良事件与临床疗效的关联：多中心回顾性研究
3. Efficacy of Nivolumab and Pembrolizumab in Patients With Advanced Non-Small-Cell Lung Cancer Needing Treatment Interruption Because of Adverse Events: A Retrospective Multicenter Analysis [J] . Ksienski Doran, Wai Elaine S., Croteau Nicole, Clinical lung cancer . 2019,第1期

机译：Nivolumab和Pembrolizumab在患有治疗中断的患者患者中的疗效因不良事件而需要治疗中断：回顾性多中心分析
4. Immune-Related Adverse Events in Cancer Patients Being Treated with Immune Checkpoint Inhibitors [D] . Byrne, Margaret M. 2021

机译：用免疫检查点抑制剂治疗癌症患者免疫相关不良事件
5. Absolute Lymphocyte Count Predicts Immune-Related Adverse Events in Patients With Non-Small-Cell Lung Cancer Treated With Nivolumab Monotherapy: A Multicenter Retrospective Study [O] . Saeka Egami, Hitoshi Kawazoe, Hironobu Hashimoto, 2021

机译：绝对淋巴细胞计数预测用Nivolumab单药治疗的非小细胞肺癌患者免疫相关不良事件：多中心回顾性研究
6. Prognosis of Immune-related Adverse Events in Patients With Advanced Gastric Cancer Treated With Nivolumab or Pembrolizumab: A Multicenter Retrospective Analysis [O] . TAKAYUKI ANDO, AKIRA UEDA, KOHEI OGAWA, 2021

机译：用Nivolumab或Pembrolizumab治疗的晚期胃癌患者免疫相关不良事件的预后：多中心回顾性分析

Absolute Lymphocyte Count Predicts Immune-Related Adverse Events in Patients With Non-Small-Cell Lung Cancer Treated With Nivolumab Monotherapy: A Multicenter Retrospective Study

著录项

引文网络

相似文献

相关主题

期刊订阅